Central and paracentral visual field defects and driving abilities

Ophthalmologica

Volumn 219, Issue 4, 2005, Pages 191-201

  Petzold, A ^a   Plant, G T ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Driving abilities; Paracentral scotoma; Visual field defects, central, paracentral

Indexed keywords

ALCOHOL; AMIODARONE; CHLOROQUINE; INTERFERON; INTERLEUKIN 2; VIGABATRIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMBLYOPIA; AUTOSOMAL DOMINANT OPTIC ATROPHY; BINOCULAR VISION; BLINDNESS; BLUNT TRAUMA; CATARACT; CENTRAL SCOTOMA; CENTRAL SEROUS RETINOPATHY; CHORIORETINITIS; DIABETIC RETINOPATHY; DISEASE EXACERBATION; DRIVER LICENCE; DRIVING ABILITY; ENDOCRINE DISEASE; EPILEPSY; EYE INJURY; FENESTRATION; GIANT CELL ARTERITIS; HEALTH SURVEY; HEMODIALYSIS; HERPES VIRUS; HERPES VIRUS INFECTION; HUMAN; HYPERTENSION; HYPOTENSION; INTRACRANIAL HYPERTENSION; ISCHEMIC OPTIC NEUROPATHY; KERATOMILEUSIS; LASER COAGULATION; LEBER HEREDITARY OPTIC NEUROPATHY; LYME DISEASE; MALNUTRITION; MIGRAINE; MONOCULAR VISION; MULTIPLE SCLEROSIS; OPTIC NERVE DISEASE; PARANEOPLASTIC SYNDROME; PRACTICE GUIDELINE; RETINA ARTERY OCCLUSION; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULOPATHY; RETINA PIGMENT EPITHELIOPATHY; RETINITIS PIGMENTOSA; RETINOTOMY; REVIEW; SCOTOMA; SLEEP APNEA SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; TOBACCO; TRAFFIC ACCIDENT; VISUAL ACUITY; VISUAL FIELD DEFECT; VITRECTOMY;

AUTOMOBILE DRIVER EXAMINATION; AUTOMOBILE DRIVING; EYE DISEASES; HUMANS; OCULAR PHYSIOLOGY; SCOTOMA; VISION, BINOCULAR; VISUAL ACUITY; VISUAL FIELDS;

EID: 23844530361     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085727     Document Type: Review

References (219)

1. Acaroglu G, Kansu T, Dogulu CF: Visual recovery patterns in children with Leber's hereditary optic neuropathy. Int Ophthalmol 2001;24:349-355.
2. Acheson JF: Vigabatrin associated visual field constriction. J Neurol Neurosurg Psychiatry 1999;67:707-708.
3. Acocella N: How drivers with poor vision stay behind the wheel. Sightsaving 1982;51:12-14.
4. Aleman TS, Cideciyan AV, Volpe NJ, et al: Spinocerebellar ataxia type 7 (SCA7) shows a cone-rod dystrophy phenotype. Exp Eye Res 2002;74:737-745.
5. Arbet TP: Multiple evanescent white dot syndrome. J Am Optom Assoc 1997;68:769-774.
6. Arima T, Uemura A, Otsuka S, Doi N, Nakao K: Macular hole surgery-associated peripheral visual field loss. Jpn J Ophthalmol 1998;42:476-483.
7. Arruga J: Metastatic and paraneoplastic lesions of the optic nerve. Rev Neurol 2000;31:1256-1258.
8. Arruga J, Valentines J, Mauri F, Roca G, Salom R, Rufi G: Neuroretinitis in acquired syphilis. Ophthalmology 1985;92:262-270.
9. Autzen T, Faurschou S: Acute posterior multifocal placoid pigment epitheliopathy. Acta Ophthalmol 1986;64:267-270.
10. Backman H: Monocular and binocular visual ability in nocturnal driving visibility. Am J Optom Arch Am Acad Optom 1972;49:680-684.
11. Bacon P, Spalton DJ, Smith SE: Blindness from quinine toxicity. Br J Ophthalmol 1988;72:219-224.
12. Barnett HJ, Gunton RW, Eliasziw M, Fleming L, Sharpe B, Gates P, Meldrum H: Causes and severity of ischemic stroke in patients with internal carotid artery stenosis. JAMA 2000;283:1429-1436.
13. Bauer A, Dietz K, Kolling G, Hart W, Schiefer U: The relevance of stereopsis for motorists: A pilot study. Graefes Arch Clin Exp Ophthalmol 2001;239:400-406.
14. Bek T: Localised scotomata and types of vascular occlusion in diabetic retinopathy. Acta Ophthalmol 1991;69:11-18.
15. Bernard JT, Ameriso S, Kempf RA, Rosen P, Mitchell MS, Fisher M: Transient focal neurologic deficits complicating interleukin-2 therapy. Neurology 1990;40:154-155.
16. Birch DG, Anderson JL, Fish GE: Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy. Ophthalmology 1999;106:258-268.
17. Birch DG, Peters AY, Locke KL, Spencer R, Megarity CF, Travis GH: Visual function in patients with cone-rod dystrophy (CRD) associated with mutations in the ABCA4(ABCR) gene. Exp Eye Res 2001;73:877-886.
18. Blodi BA, Johnson MW, Gass JD, Fine SL, Joffe LM: Purtscher's-like retinopathy after childbirth. Ophthalmology 1990;97:1654-1659.
19. Bopp S, Lucke K, Hille U: Peripheral visual field loss after vitreous surgery for macular holes. Graefes Arch Clin Exp Ophthalmol 1997;235:362-371.
20. Bourke RD, Dowler JG, Milliken AB, Cooling RJ: Perimetric and angiographic effects of retinotomy. Aust NZ J Ophthalmol 1996;24:245-249.
21. Brinton GS, Norton EW, Zahn JR, Knighton RW: Ocular quinine toxicity. Am J Ophthalmol 1980;90:403-410.
22. Brown JC, Kylstra JA, Mah ML: Entoptic perimetry screening for central diabetic scotomas and macular edema. Ophthalmology 2000;107:755-759.
23. Brown SM, Morales J: Iatrogenic ring scotoma after laser in situ keratomileusis. J Cataract Refract Surg 2002;28:1860-1863.
24. Brown J Jr, Folk JC: Current controversies in the white dot syndromes: Multifocal choroiditis, punctate inner choroidopathy, and the diffuse subretinal fibrosis syndrome. Ocul Immunol Inflamm 1998;6:125-127.
25. Buckley SA, James B: Purtscher's retinopathy. Postgrad Med J 1996;72:409-412.
26. Buckley SA, Jenkins L, Benjamin L: Fields, DVLC and panretinal photocoagulation. Eye 1992;6:623-625.
27. Buckley SA, Wheatcroft SM, Benjamin L, Jenkins L: How much blame can be placed on laser photocoagulation for failure to attain driving standards? Eye 1996;10:404-405.
28. Burkhard C, Gleichmann M, Wilhelm H: Optic nerve lesion following neuroborreliosis: A case report. Eur J Ophthahnol 2001;11:203-206.
29. Burstedt MS, Forsman-Semb K, Golovleva I, Janunger T, Wachtmeister L, Sandgren O: Ocular phenotype of bothnia dystrophy, an autosomal recessive retinitis pigmentosa associated with an R234W mutation in the RLBP1 gene. Arch Ophthalmol 2001;119:260-267.
30. Casson EJ, Racette L: Vision standards for driving in Canada and the United States: A review for the Canadian Ophthalmological Society. Can J Ophthahnol 2000;35:192-203.
31. Charman WN: Visual standards for driving. Ophthalmol Physiol Opt 1984;5:211-220.
32. Cohen SM, Davis JL, Gass DM: Branch retinal arterial occlusions in multifocal retinitis with optic nerve edema. Arch Ophthalmol 1995;113:1271-1276.
33. Connolly SE, Gordon KB, Horton JC: Salvage of vision after hypotension-induced ischemic optic neuropathy. Am J Ophthalmol 1994;117:235-242.
34. Cullinane AB, Cleary PE: Prevention of visual field defects after macular hole surgery. Br J Ophthalmol 2000;84:372-377.
35. Danesh-Meyer H, Kubis KC, Sergott RC: Not so slowly progressive visual loss. Surv Ophthalmol 1999;44:247-252.
36. Detry-Morel M, Boschi A, Gehenot M, Geubel A: Bilateral transient visual obscurations with headaches during alpha-II interferon therapy: A case report. Eur J Ophthalmol 1995;5:271-274.
37. Deutsch TA, Corwin HL: Lupus optic neuritis with negative serology. Ann Ophthalmol 1988;20:383-384.
38. Dodwell DG, Jampol LM, Rosenberg M, Berman A, Zaret CR: Optic nerve involvement associated with the multiple evanescent white-dot syndrome. Ophthalmology 1990;97:862-868.
39. Downes SM, Payne AM, Kelsell RE, Fitzke FW, Holder GE, Hunt DM, Moore AT, Bird AC: Autosomal dominant cone-rod dystrophy with mutations in the guanylate cyclase 2D gene encoding retinal guanylate cyclase-1. Arch Ophthalmol 2001;119:1667-1673.
40. Drummond PD, Anderson M: Visual field loss after attacks of migraine with aura. Cephalalgia 1992;12:349-352.
41. Easterbrook M: Long-term course of antimalarial maculopathy after cessation of treatment. Can J Ophthalmol 1992;27:237-239.
42. Ebner R, Slamovits TL, Friedland S, Pearlman JL, Fowble B: Visual loss following treatment of sphenoid sinus carcinoma. Surv Ophthalmol 1995;40:62-68.
43. Eckstein A, Kotter I, Wilhelm H: Atypical optic neuritis in systemic lupus erythematosus (SLE). Klin Monatsbl Augenheilkd 1995;207:310-313.
44. Eichers ER, Green JS, Stockton DW, Jackman CS, Whelan J, McNamara JA, Johnson GJ, Lupski JR, Katsanis N: Newfoundland rodcone dystrophy, an early-onset retinal dystrophy, is caused by splice-junction mutations in RLBP1. Am J Hum Genet 2002;70:955-964.
45. Elkington AR, MacKean JM: Glaucoma and driving. Br J Ophthalmol 1982;285:777-778.
46. Ezra E, Arden GB, Riordan-Eva P, Aylward GW, Gregor ZJ: Visual field loss following vitrectomy for stage 2 and 3 macular holes. Br J Ophthalmol 1996;80:519-525.
47. Fasce F, Brancato R, Bettin P, Introini TJ, Pece A: Evaluation of fixation one year after perifoveal laser treatment of subfoveal choroidal neovascularization. Int Ophthalmol 1996-97; 20:251-258.
48. Faschinger C, Brunner H: Visual field examinations using the Octopus computerized perimeter following laser therapy of central serous chorioretinitis (Wessing type I). Klin Monatsbl Augenheilkd 1982;181:376-378.
49. Feigl B, Faschinger C, Soyer P: Melanoma-associated retinopathy versus abnormal retinal function due to interferon-alpha/isotretinoin therapy in cutaneous malignant melanoma. Ophthalmologica 2000;214:271-276.
50. Ferguson GG, Eliasziw M, Barr HW, Clagett GP, Barnes RW, Wallace MC, Taylor DW, Haynes RB, Finan JW, Hachinski VC, Barnett HJ: The North American Symptomatic Carotid Endarterectomy Trial: Surgical results in 1,415 patients. Stroke 1999;30:1751-1758.
51. Fishman GA, Anderson RJ, Stinson L, Haque A: Driving performance of retinitis pigmentosa patients. Br J Ophthalmol 1981;65:122-126.
52. Fishman GA, Stone EM, Alexander KR, Gilbert LD, Derlacki DJ, Butler NS: Serine-27-phenylalanine mutation within the peripherin/ RDS gene in a family with cone dystrophy. Ophthalmology 1997;104:299-306.
53. Fisk GD, Owsley C, Mennemeier M: Vision, attention, and self-reported driving behaviors in community-dwelling stroke survivors. Arch Phys Med Rehabil 2002;83:469-477.
54. Foley D, Wallace R, Eberhard J: Risk factors for motor vehicle crashes amongst older drivers in a rural community. J Am Geriatr Soc 1995;43:776-782.
55. Fong KS, Fu ER: Multiple evanescent white dot syndrome - An uncommon cause for an enlarged blind spot. Ann Acad Med Singapore 1996;25:866-868.
56. Forsius H, Erkkila H, Eriksson AW: Rod-cone dystrophy of the retina: Continuation of a family study described in 1923. Acta Ophthalmol 1990;68:2-10.
57. Freigassner PS, El-Shabrawi Y: Optic nerve involvement in syphilis in 4 patients. Klin Monatsbl Augenheilkd 2001;218:691-694.
58. Friedman DI, Hu EH, Sadun AA: Neuro-ophthalmic complications of interleukin 2 therapy. Arch Ophthalmol 1991;109:1679-1680.
59. Fuhrmeister H: A long-term study of morphological and functional developments after central serous chorioretinitis. Klin Monatsbl Augenheilkd 1983;182:549-551.
60. Gass JD, Tiedeman J, Thomas MA: Idiopathic recurrent branch retinal arterial occlusion. Ophthalmology 1986;93:1148-1157.
61. Gerth C, Andrassi-Darida M, Bock M, Preising MN, Weber BH, Lorenz B: Phenotypes of 16 Stargardt macular dystrophy/fundus flavimaculatus patients with known ABCA4 mutations and evaluation of genotype-phenotype correlation. Graefes Arch Clin Exp Ophthalmol 2002;240:628-638.
62. Goen TM, Terry JE: Acute posterior multifocal placoid pigment epitheliopathy. J Am Optom Assoc 1987;58:112-117.
63. Goldstein SM, Syed NA, Milam AH, Maguire AM, Lawton TJ, Nichols CW: Cancer-associated retinopathy. Arch Ophthalmol 1999;117:1641-1645.
64. Gomez CR, Bhat MH, Chung HD: Homonymous quadrantic visual field defect resulting from vertebrobasilar insufficiency: Report of a case. Angiology 1990;41:151-155.
65. Goyal S, Riordan-Eva P, Coakes RL: Late onset of Leber's hereditary optic neuropathy precipitated by anaemia. Eye 2004;18:1017-1018.
66. Green RP Jr, Carlson DW, Dieckert JP, Tredici TJ: Central serous chorioretinopathy in US Air Force aviators: A review. Aviat Space Environ Med 1988;59:1170-1175.
67. Greven CM, Singh T, Stanton CA, Martin TJ: Optic chiasm, optic nerve, and retinal involvement secondary to varicella-zoster virus. Arch Ophthalmol 2001;119:608-610.
68. Guthauser U, Flammer J: Quantifying visual field damage caused by cataract. Am J Ophthalmol 1988;106:480-484.
69. Hamed LM, Glaser JS, Gass JD, Schatz NJ: Protracted enlargement of the blind spot in multiple evanescent white dot syndrome. Arch Ophthalmol 1989;107:194-198.
70. Hart WM Jr, Burde RM, Johnston GP, Drews RC: Static perimetry in chloroquine retinopathy: Perifoveal patterns of visual field depression. Arch Ophthalmol 1984;102:377-380.
71. Hayreh SS: Pathogenesis of occlusion of the central retinal vessels. Am J Ophthalmol 1971;72:998-1011.
72. Hayreh SS: Anterior ischemic optic neuropathy. Clin Neurosci 1997;4:251-263.
73. Hayreh SS, Podhajsky P, Zimmerman MB: Role of nocturnal arterial hypotension in optic nerve head ischemic disorders. Ophthalmologica 1999;213:76-96.
74. Hayreh SS, Zimmerman B, Kardon RH: Visual improvement with corticosteroid therapy in giant cell arteritis: Report of a large study and review of literature. Acta Ophthalmol Scand 2002;80:355-367.
75. Hayreh SS, Zimmerman MB, Podhajsky P, Alward WL: Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol 1994;117:603-624.
76. Heller-Bettinger I, Kepes JJ, Preskorn SH, Wurster JB: Bilateral altitudinal anopia caused by infarction of the calcarine cortex. Neurology 1976;26:1176-1179.
77. Hickman SJ, Dalton CM, Miller DH, Plant GT: Management of acute optic neuritis. Lancet 2002;360:1953-1962.
78. Holopigian K, Seiple W, Greenstein VC, Hood DC, Carr RE: Local cone and rod system function in progressive cone dystrophy. Invest Ophthalmol Vis Sci 2002;43:2364-2373.
79. Holt LJ, Anderson SF: Bilateral occipital lobe stroke with inferior altitudinal defects. Optometry 2000;71:690-702.
80. Hulbert MF, Vernon SA: Passing the DVLC field regulations following bilateral pan-retinal photocoagulation in diabetics. Eye 1992;6:456-460.
81. Igarashi T, Ishigatsubo Y, Motoji K, Takeshita F, Ohta S, Sumino K, Soga T, Shirai A, Ohno S, Okubo T: Optic neuropathy in systemic lupus erythematosus (SLE) - Analysis of 54 cases including our case. Ryumachi 1995;35:32-37.
82. Ikaheimo K, Kettunen R, Mantyjarvi M: Visual functions and adverse ocular effects in patients with amiodarone medication. Acta Ophthalmol Scand 2002;80:59-63.
83. Im CY, Kim SS, Kim HK: Bilateral optic neuritis as first manifestation of systemic lupus erythematosus. Korean J Ophthalmol 2002;16:52-58.
84. Isa K, Miyashita K, Yanagimoto S, Nagatsuka K, Naritomi H: Homonymous defect of macular vision in ischemic stroke. Eur Neurol 2001;46:126-130.
85. Ivers RQ, Mitchell P, Cumming RG: Lack of association between localized cataract and visual field loss: The Blue Mountains Eye Study. Aust NZ J Ophthalmol 1997;25:193-198.
86. Jacobson DM, Thirkill CE, Tipping SJ: A clinical triad to diagnose paraneoplastic retinopathy. Ann Neurol 1990;28:162-167.
87. Jarrell RL 3rd, Jones WL: Juxtapapillary nerve fiber layer infarction as a complication of coronary artery bypass surgery. J Am Optom Assoc 1998;69:759-765.
88. Johnson CA, Keltner JL: Incidence of visual field loss in 20,000 eyes and its relationship to driving performance. Arch Ophthalmol 1983;101:371-375.
89. Johnson MW, Thomley ML, Huang SS, Gass JD: Idiopathic recurrent branch retinal arterial occlusion: Natural history and laboratory evaluation. Ophthalmology 1994;101:480-489.
90. Josephson JE, Erickson P, Back A, Holden BA, Harris M, Tomlinson A, Caffrey BE, Finnemore V, Silbert J: Monovision. J Am Optom Assoc 1990;61:820-826.
91. Kaiser HJ, Flammer J: Systemic hypotension: A risk factor for glaucomatous damage? Ophthalmologica 1991;203:105-108.
92. Keeney AH: Relationship of ocular pathology and driving impairment. Trans Am Acad Ophthalmol Otolaryngol 1968;72:737-740.
93. Keeney AH, Garvey J: The dilemma of the monocular driver. Am J Ophthalmol 1981;91:801-803.
94. Kellner U, Bornfeld N, Foerster MH: Severe course of cutaneous melanoma associated paraneoplastic retinopathy. Br J Ophthalmol 1995;79:746-752.
95. Keltner JL, Thirkill CE, Yip PT: Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: Eleven new cases and a review of 51 previously published cases. J Neuroophthalmol 2001;21:173-187.
96. Kerrison JB, Pollock SC, Biousse V, Newman NJ: Coffee and doughnut maculopathy: A cause of acute central ring scotomas. Br J Ophthalmol 2000;84:158-164.
97. Kitajima M, Korogi Y, Kido T, Ikeda O, Morishita S, Takahashi M: MRI in occipital lobe infarcts: Classification by involvement of the striate cortex. Neuroradiology 1998;40:710-715.
98. Kite CR, King JN: A survey of the factors limiting the visual fields of motor vehicle drivers in relation to minimum visual fields and visibility standards. Br J Physiol Opt 1961;18:85-107.
99. Knecht J: The multiple sclerosis patient as a driver. Schweiz Med Wochenschr 1977;107:373-378.
100. Krauss GL, Johnson MA, Sheth S, Miller NR: A controlled study comparing visual function in patients treated with vigabatrin and tiagabine. J Neurol Neurosurg Psychiatry 2003;74:339-343.
101. Krieg P, Schipper I: Bilateral optic neuropathy following amiodarone therapy. Klin Monatsbl Augenheilkd 1992;200:128-132.
102. Krist D, Wenkel H: Bilateral papillary edema in cerebrospinal syphilis. Klin Monatsbl Augenheilkd 2000;216:54-56.
103. Krolak-Salmon P, Guenot M, Tiliket C, Isnard J, Sindou M, Mauguiere F, Vighetto A: Anatomy of optic nerve radiations as assessed by static perimetry and MRI after tailored temporal lobectomy. Br J Ophthalmol 2000;84:884-889.
104. Krumsiek J, Kruger C, Patzold U: Tobacco-alcohol amblyopia neuro-ophthalmological findings and clinical course. Acta Neurol Scand 1985;72:180-187.
105. Krumsiek J, Kruger C, Wurster U, Patzold U: Tobacco-alcohol amblyopia: Clinical course in 33 patients. Fortschr Neurol Psychiatr 1985;53:88-93.
106. Lakhanpal A, Selhorst JB: Bilateral altitudinal visual fields. Ann Ophthalmol 1990;22:112-117.
107. Lam BL, Alward WL, Kolder HE: Effect of cataract on automated perimetry. Ophthalmology 1991;98:1066-1070.
108. Larkin DF, Wood AE, Neligan M, Eustace P: Ischaemic optic neuropathy complicating cardiopulmonary bypass. Br J Ophthalmol 1987;71:344-347.
109. Lee AG, Golnik K, Kardon R, Wall M, Eggenberger E, Yedavally S: Sleep apnea and intracranial hypertension in men. Ophthalmology 2002;109:482-485.
110. Leifert D, Hansen LL, Gerling J: Amiodarone-associated optic neuropathy: An independent syndrome? Three patients with bilateral optic neuropathy. Klin Monatsbl Augenheilkd 2000;217:171-177.
111. Leismaa M: The influence of driver's vision in relation to his driving ability. Optician 1973;166:10-13.
112. Lerman Y, Matar M, Lavie B, Danon YL: Effect of valvular heart diseases, migraine headaches, and perianal diseases on the risk of involvement in motor vehicle crashes. J Trauma 1995;39:1058-1062.
113. Leys AM, Schonherr U, Lang GE, Naumann GO, Goubau P, Honore A, Valvekens F: Retinal vasculitis in Lyme borreliosis. Bull Soc Belge Ophtalmol 1995;259:205-214.
114. Leys M, Van Slycken S, Koller J, et al: Acute macular neuroretinopathy after shock. Bull Soc Belge Ophthalmol 1991;241:95-104.
115. Lings S: Driving accident frequency increased in patients with multiple sclerosis. Acta Neurol Scand 2002;105:169-173.
116. Lip PL, Good PA, Gibson JM: Sorsby's fundus dystrophy: A case report of 24 years follow-up with electrodiagnostic tests and indocyanine green angiography. Eye 1999;13:16-25.
117. Lorenz B, Gyurus P, Preising M, Bremser D, Gu S, Andrassi M, Gerth C, Gal A: Early-onset severe rod-cone dystrophy in young children with RPE65 mutations. Invest Ophthalmol Vis Sci 2000;41:2735-2742.
118. Lövsund P, Hedin A, Tornros J: Effects on driving performance of visual field defects: A driving simulator study. Accid Anal Prev 1991;23:331-342.
119. Mackie SW, Webb LA, Hutchison BM, Hammer HM, Barrie T, Walsh G: How much blame can be placed on laser photocoagulation for failure to attain driving standards? Eye 1995;9:517-525.
120. Man PY, Turnbull DM, Chinnery PF: Leber hereditary optic neuropathy. J Med Genet 2002;39:162-169.
121. Manesis EK, Moschos M, Brouzas D, Kotsiras J, Petrou C, Theodosiadis G, Hadziyannis S: Neurovisual impairment: A frequent complication of alpha-interferon treatment in chronic viral hepatitis. Hepatology 1998;27:1421-1427.
122. Manic H, Boissonnot M, Gicquel JJ, Rovira JC, Dighiero P: Leber's idiopathic stellate neuroretinitis: About two cases. J Fr Ophtalmol 2003;26:59-63.
123. Manji H, Plant GT: Epilepsy surgery, visual fields, and driving: A study of the visual field criteria for driving in patients after temporal lobe epilepsy surgery with a comparison of Goldmann and Esterman perimetry. J Neurol Neurosurg Psychiatry 2000;68:80-82.
124. Mansour AM: Neuro-ophthalmic findings in acquired immunodeficiency syndrome. J Clin Neuroophthalmol 1990;10:167-174.
125. Mantyjarvi M, Tuppurainen K: Cataract in traffic. Graefes Arch Clin Exp Ophthalmol 1999;237:278-282.
126. Mantyjarvi M, Tuppurainen K, Rouhiainen H: Visual function in professional truck drivers. Int Arch Occup Environ Health 1998;71:357-362.
127. Mashima Y, Sato EA, Ohde H, Oguchi Y: Macular nerve fibers temporal to fovea may have a greater potential to recover function in patients with Leber's hereditary optic neuropathy. Jpn J Ophthalmol 2002;46:660-667.
128. McKnight AJ, Shinar D, Hilburn B: The visual and driving performance of monocular and binocular heavy truck drivers. Acc Anal Prev 1991;23:225-237.
129. McKnight AJ, Shinar D, Hilburn B: The visual and driving performance of monocular and binocular heavy-duty truck drivers. Accid Anal Prev 1991;23:225-237.
130. McLean IM, Mueller E, Buttery RG, Mackey DA: Visual field assessment and the Austroads driving standard. Clin Exp Ophthalmol 2002;30:3-7.
131. Miedziak AI, Perski T, Andrews PP, Donoso LA: Stargardt's macular dystrophy - A patient's perspective. Optometry 2000;71:165-176.
132. Miller NR: Visual manifestations of temporal arteritis. Rheum Dis Clin North Am 2001;27:781-797.
133. Miyashita K, Kigasawa K, Mashima Y, Fujino T: Superior altitudinal hemianopia and herpes zoster. Ann Ophthalmol 1993;25:20-23.
134. Mojon DS, Mathis J, Zulauf M, Koerner F, Hess CW: Optic neuropathy associated with sleep apnea syndrome. Ophthalmology 1998;105:874-877.
135. Moorthy RS, Valluri S: Oculartoxicity associated with systemic drug therapy. Curr Opin Ophthalmol 1999;10:438-446.
136. Moroi SE, Gottfredsdottir MS, Van Heck T, Musch DC, Johnson MW: Visual field results after vitreous surgery in a case series of patients with open-angle glaucoma. Ophthalmic Surg Lasers 2000;31:380-386.
137. Moster ML: Visual loss after coronary artery bypass surgery. Surv Ophthalmol 1998;42:453-457.
138. Mourant R, Rockwell T: Mapping eye movement patterns to the visual scene in driving: An exploratory study. Human Factors 1970;12:81-87.
139. Nagra PK, Foroozan R, Savino PJ, Castillo I, Sergott RC: Amiodarone induced optic neuropathy. Br J Ophthalmol 2003;87:420-422.
140. Nakajima N, Noda S, Hayasaka S: Unilateral acute posterior multifocal placoid pigment epitheliopathy. Ophthalmologjca 1996;210:123-125.
141. Nakazawa M, Naoi N, Wada Y, Nakazaki S, Maruiwa F, Sawada A, Tamai M: Autosomal dominant cone-rod dystrophy associated with a Val200Glu mutation of the peripherin/RDS gene. Retina 1996;16:405-410.
142. Naraqi S, Okem S, Moyia N, Dutta TK, Zzferio B, Lalloo D: Quinine blindness. P N G Med J 1992;35:308-310.
143. Nazarian SM, Jay WM: Bilateral optic neuropathy associated with amiodarone therapy. J Clin Neuroophthalmol 1988;8:25-28.
144. Neubauer AS, Hoops JP: Bilateral retinal microangiopathy in interferon therapy of malignant melanoma of the skin. Klin Monatsbl Augenheilkd 2000;217:308-311.
145. Newman WD, Tocher K, Acheson JF: Vigabatrin associated visual field loss: A clinical audit to study prevalence, drug history and effects of drug withdrawal. Eye 2002;16:567-571.
146. O'Brien DM, Farmer SG, Kalina RE, Leon JA: Acute macular neuroretinopathy following intravenous sympathomimetics. Retina 1989;9:281-286.
147. Okuyama M, Okisaka S: Automatic static threshold perimetry is useful for estimating the effects of laser photocoagulation on diabetic maculopathy. Ophthalmic Res 1998;30:207-215.
148. Ormerod LD, Rhodes RH, Gross SA, Crane LR, Houchin KW: Ophthalmologic manifestations of acquired immune deficiency syndrome-associated progressive multifocal leukoencephalopathy. Ophthalmology 1996;103:899-906.
149. Owsley C, McGwin G Jr: Vision impairment and driving. Surv Ophthalmol 1999;43:535-550.
150. Pahor D: Retinal light sensitivity in haemodialysis patients. Eye 2003;17:177-182.
151. Paques M, Massin P, Santiago PY, Spielmann AC, Gaudric A: Visual field loss after vitrectomy for full-thickness macular holes. Am J Ophthalmol 1997;124:88-94.
152. Parish RK, Gedde S, Scott IU, et al: Visual function and quality of life among patients with glaucoma. Arch Ophthalmol 1997;115:1447-1455.
153. Pathak-Ray V, Ray A, Walters R, Hatfield R: Detection of visual field defects in patients after anterior temporal lobectomy for mesial temporal sclerosis - Establishing eligibility to drive. Eye 2002;16:744-748.
154. Pearson AR, Keightley SJ, Casswell AG: How good are we at assessing driving visual fields in diabetics? Eye 1998;12:938-942.
155. Pearson AR, Tanner V, Keightley SJ, Casswell AG: What effect does laser photocoagulation have on driving visual fields in diabetics? Eye 1998;12:64-68.
156. Pendergast SD, McCuen BW 2nd: Visual field loss after macular hole surgery. Ophthalmology 1996;103:1069-1077.
157. Percival SP: The ocular toxicity of chloroquine. Trans Ophthalmol Soc UK 1967;87:355-307.
158. Petzold A, Islam N, Plant GT: Transient monocular blindness: The controversial role of the ophthalmic artery. J Neurol 2004;251:1178-1180.
159. Potts AM: Tobacco amblyopia. Surv Ophthalmol 1973;17:313-339.
160. Purvin VA: Anterior ischemic optic neuropathy secondary to interferon alfa. Arch Ophthalmol 1995;113:1041-1044.
161. Purvin VA, Kawasaki A, Yee RD: Papilledema and obstructive sleep apnea syndrome. Arch Ophthalmol 2000;118:1626-1630.
162. Ray A, Pathak-Ray V, Walters R, Hatfield R: Driving after epilepsy surgery: Effects of visual field defects and epilepsy control. Br J Neurosurg 2002;16:456-460.
163. Reading RW, Hofstetter HW: Effect of monocular and binocular vision in vehicle driving speeds. Am J Optom Arch Am Acad Optom 1969;46:954-959.
164. Richer S: A protocol for the evaluation and treatment of atrophic age-related macular degeneration. J Am Optom Assoc 1999;70:13-23.
165. Riedel KG, Gilg T, Liebhardt E: Perceptual disorders of the peripheral visual field caused by alcohol: Studies with the automatic Octopus perimeter. Klin Monatsbl Augenheilkd 1985;186:279-283.
166. Rizzo JF 3rd, Lessell S: Choroidal infarction after optic nerve sheath fenestration. Ophthalmology 1994;101:1622-1626.
167. Roberts SP, Schaumberg DA, Thompson P: Traumatic avulsion of the optic nerve. Optom Vis Sci 1992;69:721-727.
168. Roge J, Pebayle T, Hannachi SE, Muzet A: Effect of sleep deprivation and driving duration on the useful visual field in younger and older subjects during simulator driving. Vision Res 2003;43:1465-1472.
169. Roncone DP: Purtscher's retinopathy. Optometry 2002;73:166-172.
170. Rothova A, Suttorp-van Schulten MS, Frits Treffers W, Kijlstra A: Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 1996;80:332-336.
171. Rowe FJ, Sarkies NJ: Assessment of visual function in idiopathic intracranial hypertension: Aprospective study. Eye 1998;12:111-118.
172. Ruckhofer J, Grabner G: Das Fahrverhalten von Patienten vor Operation des grauen Stars - Ist der unbefristete Führerschein vertretbar? Klin Monatsbl Augenheilkd 1998;212:106-110.
173. Russell-Eggitt IM, Mackey DA, Taylor DS, Timms C, Walker JW: Vigabatrin-associated visual field defects in children. Eye 2000;14:334-339.
174. Ruther K, Banhart F, et al: Social ophthalmologic aspects of retinitis pigmentosa. Ophthalmologe 1995;92:704-707.
175. Sadun AA, Carelli V, Salomao SR, Berezovsky A, Quiros P, Sadun F, DeNegri AM, Andrade R, Schein S, Belfort R: A very large Brazilian pedigree with 11778 Leber's hereditary optic neuropathy. Trans Am Ophthalmol Soc 2002;100:169-178, discussion 178-179.
176. Sadun AA, Carelli V, Salomao SR, Berezovsky A, Quiros PA, Sadun F, DeNegri AM, Andrade R, Moraes M, Passos A, Kjaer P, Pereira J, Valentino ML, Schein S, Belfort R: Extensive investigation of a large Brazilian pedigree of 11778/haplogroup J Leber hereditary optic neuropathy. Am J Ophthalmol 2003;136:231-238.
177. Samples JR, Younge BR: Tobacco-alcohol amblyopia. J Clin Neuroophthalmol 1981;1:213-218.
178. Schiefer U, Hofer R, Vischer PM, Wilhelm H: Perimetriebefund und Fahrtauglichkeit. Ophthalmologe 2000;97:491-497.
179. Schulman JA, Liang C, Kooragayala LM, King J: Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin. Ophthalmology 2003;110:437-442.
180. Schultkeis MT, Garay E, Millis SR, Deluca J: Motor vehicle crashes and violations among drivers with multiple sclerosis. Arch Phys Med Rehabil 2002;83:1175-1178.
181. Scilley K, Jackson GR, Cideciyan AV, Maguire MG, Jacobson SG, Owsley C: Early age-related maculopathy and self-reported visual difficulty in daily life. Ophthalmology 2002;109:1235-1242.
182. Seemongal-Dass RR, Spencer SR: Bilateral optic neuropathy linked with amiodarone. Eye 1998;12:474-477.
183. Shaw PJ, Bates D, Cartlidge NE, Heaviside D, French JM, Julian DG, Shaw DA: Neuroophthalmological complications of coronary artery bypass graft surgery. Acta Neurol Scand 1987;76:1-7.
184. Shawaryn MA, Schultheis MT, Garay E, Deluca J: Assessing functional status: Exploring the relationship between the multiple sclerosis functional composite and driving. Arch Phys Med Rehabil 2002;83:1123-1129.
185. Shinoda K, Ohde H, Inoue R, Ishida S, Mashima Y, Oguchi Y: ON-pathway disturbance in two siblings. Acta Ophthalmol Scand 2002;80:219-223.
186. Singh K, de Frank MP, Shults WT, Watzke RC: Acute idiopathic blind spot enlargement: A spectrum of disease. Ophthalmology 1991;98:497-502.
187. Smilkstein MJ, Kulig KW, Rumack BH: Acute toxic blindness: Unrecognized quinine poisoning. Ann Emerg Med 1987;16:98-101.
188. Spiegelmann R, Nissim O, Menhel J, Alezra D, Pfeffer MR: Linear accelerator radiosurgery for meningiomas in and around the cavernous sinus. Neurosurgery 2002;51:1373-1379.
189. Stone EM, Newman NJ, Miller NR, Johns DR, Lott MT, Wallace DC: Visual recovery in patients with Leber's hereditary optic neuropathy and the 11778 mutation. J Clin Neuroophthalmol 1992;12:10-14.
190. Striph GG, Hart WM Jr, Olk RJ: Modified grid laser photocoagulation for diabetic macular edema: The effect on the central visual field. Ophthalmology 1988;95:1673-1679.
191. Sullivan-Mee M, Bowman B: Migraine-related visual-field loss with prolonged recovery. J Am Optom Assoc 1997;68:377-388.
192. Susac JO: Susac's syndrome: The triad of microangiopathy of the brain and retina with hearing loss in young women. Neurology 1994;44:591-593.
193. Susac JO, Hardman JM, Selhorst JB: Microangiopathy of the brain and retina. Neurology 1979;29:313-316.
194. Swann PG, Lovie-Kitchin JE: Age-related maculopathy. II. The nature of the central visual field loss. Ophthalmic Physiol Opt 1991;11:59-70.
195. Szlyk JP, Alexander KR, Severing K, Fishman GA: Assessment of driving performance in patients with retinitis pigmentosa. Arch Ophthalmol 1992;110:1709-1713.
196. Szlyk JP, Fishman GA, Grover S, Revelins BI, Derlacki DJ: Difficulty in performing everyday activities in patients with juvenile macular dystrophies: Comparison with patients with retinitis pigmentosa. Br J Ophthalmol 1998;82:1372-1376.
197. Szlyk JP, Fishman GA, Severing K, Alexander KR, Viana M: Evaluation of driving performance in patients with juvenile macular dystrophies. Arch Ophthalmol 1993;111:207-212.
198. Szlyk JP, Pizzimenti CE, Fishman GA, Kelsch R, Wetzel LC, Kagan S, Ho K: A comparison of driving in older subjects with and without age-related macular degeneration. Arch Ophthalmol 1995;113:1033-1040.
199. Talks SJ, Good P, Clough CG, Beevers DG, Dodson PM: The acute and long-term ocular effects of accelerated hypertension: A clinical and electrophysiological study. Eye 1996;10:321-327.
200. Teitelbaum BA: Asymptomatic unilateral microembolic retinopathy secondary to percutaneous transluminal coronary angioplasty. J Am Optom Assoc 1999;70:587-592.
201. Tejada Palacios P, Pina Hurtado E, Mendez Romas MJ: Multiple evanescent white dot syndrome. Ann Ophthalmol 1993;25:216-218.
202. Thalmann H: The monocular driver in street traffic. Schweiz Med Wochenschr 1971;101:981-987.
203. Tong L, Vernon SA: Passing the DVLA field regulations following bilateral macular photocoagulation in diabetics. Eye 2000;14:35-38.
204. Van Ghelue M, Eriksen HL, Ponjavic V, Fagerheim T, Andreasson S, Forsman-Semb K, Sandgren O, Holmgren G, Tranebjaerg L: Autosomal dominant cone-rod dystrophy due to a missense mutation (R838C) in the guanylate cyclase 2D gene (GUCY2d) with preserved rod function in one branch of the family. Ophthalmic Genet 2000;21:197-209.
205. Votruba M, Fitzke FW, Holder GE, Carter A, Bhattacharya SS, Moore AT: Clinical features in affected individuals from 21 pedigrees with dominant optic atrophy. Arch Ophthalmol 1998;116:351-358.
206. Votruba M, Moore AT, Bhattacharya SS: Clinical features, molecular genetics, and pathophysiology of dominant optic atrophy. J Med Genet 1998;35:793-800.
207. Wada Y, Abe T, Sato H, Tamai M: A novel Gly35Ser mutation in the RDH5 gene in a Japanese family with fundus albipunctatus associated with cone dystrophy. Arch Ophthalmol 2001;119:1059-1063.
208. Wall M, George D: Idiopathic intracranial hypertension: A prospective study of 50 patients. Brain 1991;114:155-180.
209. Walsh FB, Hoyt WF (eds): Clinical NeuroOphthalmology, ed 3. Baltimore, Williams & Wilkins, 1969.
210. Wein F, Miller NR: An unusual homonymous visual field defect. Surv Ophthalmol 2000;44:324-328.
211. Westlake W: Is a one eyed racing driver safe to compete? Formula one (eye) or two? Br J Ophthalmol 2001;85:619-624.
212. Williams DF, Mieler WF, Williams GA: Posterior segment manifestations of ocular trauma. Retina 1990;10(suppl 1):S35-44.
213. Wilson LA, Warlow CP, Russell RW: Cardiovascular disease in patients with retinal arterial occlusion. Lancet 1979;i:292-294.
214. Wolf MD, Alward WL, Folk JC: Long-term visual function in acute posterior multifocal placoid pigment epitheliopathy. Arch Ophthalmol 1991;109:800-803.
215. Wood JM, Troutbeck R: Effect of visual impairment on driving. Hum Factors 1994;36:476-487.
216. Woon C, Tang RA, Pardo G: Nutrition and optic nerve disease. Semin Ophthalmol 1995;10:195-202.
217. Wroblewski JJ, Wells JA 3rd, Eckstein A, Fitzke F, Jubb C, Keen TJ, Inglehearn C, Bhattacharya S, Arden GB, Jay M, et al: Macular dystrophy associated with mutations at codon 172 in the human retinal degeneration slow gene. Ophthalmology 1994;101:12-22.
218. Yang Z, Peachey NS, Moshfeghi DM, Thirumalaichary S, Chorich L, Shugart YY, Fan K, Zhang K: Mutations in the RPGR gene cause X-linked cone dystrophy. Hum Mol Genet 2002;11:605-611.
219. Zaidman GW: Neurosyphilis and retrobulbar neuritis in a patient with AIDS. Ann Ophthalmol 1986;18:260-261.